HK1212898A1 - 酮洛芬的局部組合物 - Google Patents
酮洛芬的局部組合物Info
- Publication number
- HK1212898A1 HK1212898A1 HK16100881.4A HK16100881A HK1212898A1 HK 1212898 A1 HK1212898 A1 HK 1212898A1 HK 16100881 A HK16100881 A HK 16100881A HK 1212898 A1 HK1212898 A1 HK 1212898A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- ketoprofen composition
- topical
- topical ketoprofen
- composition
- ketoprofen
- Prior art date
Links
- DKYWVDODHFEZIM-UHFFFAOYSA-N ketoprofen Chemical compound OC(=O)C(C)C1=CC=CC(C(=O)C=2C=CC=CC=2)=C1 DKYWVDODHFEZIM-UHFFFAOYSA-N 0.000 title 1
- 229960000991 ketoprofen Drugs 0.000 title 1
- 230000000699 topical effect Effects 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P23/00—Anaesthetics
- A61P23/02—Local anaesthetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Dermatology (AREA)
- Inorganic Chemistry (AREA)
- Pain & Pain Management (AREA)
- Anesthesiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Rheumatology (AREA)
- Engineering & Computer Science (AREA)
- Dispersion Chemistry (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201261706163P | 2012-09-27 | 2012-09-27 | |
US13/826,706 US8822537B2 (en) | 2012-09-27 | 2013-03-14 | Topical ketoprofen composition |
PCT/US2013/061403 WO2014052313A1 (en) | 2012-09-27 | 2013-09-24 | Topical ketoprofen composition |
Publications (1)
Publication Number | Publication Date |
---|---|
HK1212898A1 true HK1212898A1 (zh) | 2016-06-24 |
Family
ID=50339476
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK16100881.4A HK1212898A1 (zh) | 2012-09-27 | 2016-01-27 | 酮洛芬的局部組合物 |
Country Status (14)
Country | Link |
---|---|
US (1) | US8822537B2 (zh) |
EP (1) | EP2900231B1 (zh) |
JP (1) | JP6238991B2 (zh) |
KR (1) | KR102184245B1 (zh) |
AU (1) | AU2013323766B2 (zh) |
BR (1) | BR112015006790B1 (zh) |
CA (1) | CA2885619C (zh) |
ES (1) | ES2902850T3 (zh) |
HK (1) | HK1212898A1 (zh) |
IL (1) | IL237810B (zh) |
MX (1) | MX2015004006A (zh) |
NZ (1) | NZ706108A (zh) |
RU (1) | RU2652345C2 (zh) |
WO (1) | WO2014052313A1 (zh) |
Families Citing this family (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP3485881B1 (en) | 2009-07-10 | 2024-03-13 | President and Fellows of Harvard College | Permanently charged sodium and calcium channel blockers as anti-inflammatory agents |
EP3226972A4 (en) * | 2014-12-01 | 2018-08-08 | Achelios Therapeutics, Inc. | Methods and compositions for treating migraine and conditions associated with pain |
JP6833811B2 (ja) | 2015-08-03 | 2021-02-24 | プレジデント アンド フェローズ オブ ハーバード カレッジ | 荷電イオンチャネル遮断薬及び使用方法 |
JP2018537503A (ja) * | 2015-12-16 | 2018-12-20 | アケリオス セラピューティクス,インコーポレーテッド | 末梢神経障害を治療するための方法及び組成物 |
EP3435978A4 (en) * | 2016-03-31 | 2019-12-11 | Smartech Topical, Inc. | RELEASE SYSTEM |
BR112020009719A2 (pt) * | 2017-11-30 | 2020-10-27 | Aziende Chimiche Riunite Angelini Francesco A.C.R.A.F. S.P.A | composição aquosa |
US10828287B2 (en) | 2019-03-11 | 2020-11-10 | Nocion Therapeutics, Inc. | Charged ion channel blockers and methods for use |
US10780083B1 (en) | 2019-03-11 | 2020-09-22 | Nocion Therapeutics, Inc. | Charged ion channel blockers and methods for use |
WO2020185881A1 (en) | 2019-03-11 | 2020-09-17 | Nocion Therapeutics, Inc. | Charged ion channel blockers and methods for use |
US11377422B2 (en) | 2019-03-11 | 2022-07-05 | Nocion Therapeutics, Inc. | Charged ion channel blockers and methods for use |
CA3129089A1 (en) | 2019-03-11 | 2020-09-17 | Bridget Mccarthy Cole | Ester substituted ion channel blockers and methods for use |
EP4054586A4 (en) | 2019-11-06 | 2023-11-22 | Nocion Therapeutics, Inc. | CHARGED ION CHANNEL BLOCKERS AND METHODS OF USE |
MX2022005168A (es) * | 2019-11-06 | 2022-06-08 | Smartech Topical Inc | Formulaciones topicas de inhibidores de la ciclooxigenasa y su uso. |
JP2023500891A (ja) | 2019-11-06 | 2023-01-11 | ノシオン セラピューティクス,インコーポレイテッド | 荷電したイオンチャンネル遮断薬および使用方法 |
WO2021183639A1 (en) | 2020-03-11 | 2021-09-16 | Nocion Therapeutics, Inc. | Charged ion channel blockers and methods for use |
Family Cites Families (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS60155111A (ja) * | 1983-10-20 | 1985-08-15 | Hisamitsu Pharmaceut Co Inc | 安定なケトプロフェン含有外用経皮製剤 |
US5863527A (en) * | 1996-09-04 | 1999-01-26 | The Proctor & Gamble Company | Personal care compositions |
US6423697B1 (en) * | 1999-01-14 | 2002-07-23 | Mark Friedman | Intraoral topical anti-inflammatory treatment for relief of migraine, tension-type headache, post-traumatic headache, facial pain, and cervical-muscle spasm |
FR2804024B1 (fr) * | 2000-01-21 | 2002-09-13 | Menarini France | Nouvelles compositions pharmaceutiques a action anti- inflammatoire et leur procede de preparation |
US6613341B2 (en) * | 2001-05-30 | 2003-09-02 | The Procter & Gamble Company | Topical composition comprising a substituted cosmetic bonding agent |
DE10141258B4 (de) * | 2001-08-23 | 2004-09-23 | Beiersdorf Ag | Kosmetische und dermatologische Zubereitung und ihre Verwendung |
US7235230B2 (en) * | 2001-10-24 | 2007-06-26 | Clariant Finance (Bvi) Limited | Leave-on compositions for personal care |
ITFI20030070A1 (it) * | 2003-03-18 | 2004-09-19 | Berlin Chemie Ag | Formulazioni topiche stabilizzate contenenti ketoprofene |
EP1488787A1 (en) * | 2003-06-20 | 2004-12-22 | Berlin-Chemie Ag | Topical stabilized formulations containing ketoprofen |
BRPI0414551B8 (pt) * | 2003-10-10 | 2021-05-25 | Antares Pharma Ipl Ag | formulação farmacêutica transdérmica ou transmucosa e método de protelação ou inibição da cristalização de um agente ativo |
US7928144B2 (en) * | 2004-06-15 | 2011-04-19 | Hisamitsu Pharmaceutical Co., Inc. | Antiinflammatory and analgesic preparation for external use |
PT1872796E (pt) * | 2005-02-25 | 2011-11-03 | Hisamitsu Pharmaceutical Co | Preparação transdérmica para uso externo contendo um agente anti-inflamatório/analgésico não esteróide |
CA2619073A1 (en) * | 2005-09-15 | 2007-03-22 | Biomas Ltd. | Use of tellurium compounds for protection from ultra-violet radiation |
KR20090004980A (ko) * | 2006-04-18 | 2009-01-12 | 디에스엠 아이피 어셋츠 비.브이. | 살리실산 및 아스코브산을 포함하는 화장품 조성물 |
WO2009139817A2 (en) * | 2008-04-15 | 2009-11-19 | Sarcode Corporation | Crystalline pharmaceutical and methods of preparation and use thereof |
US8409600B2 (en) * | 2009-01-23 | 2013-04-02 | J&E Solutions, Llc | Methods for prevention and/or treatment of capsular contracture |
AU2010330747B2 (en) * | 2009-12-18 | 2016-08-11 | Achelios Therapeutics, Inc. | Methods and compositions for treating and preventing trigeminal autonomic cephalgias, migraine, and vascular conditions |
-
2013
- 2013-03-14 US US13/826,706 patent/US8822537B2/en active Active
- 2013-09-24 ES ES13842525T patent/ES2902850T3/es active Active
- 2013-09-24 EP EP13842525.1A patent/EP2900231B1/en active Active
- 2013-09-24 MX MX2015004006A patent/MX2015004006A/es active IP Right Grant
- 2013-09-24 JP JP2015534599A patent/JP6238991B2/ja active Active
- 2013-09-24 CA CA2885619A patent/CA2885619C/en active Active
- 2013-09-24 KR KR1020157010840A patent/KR102184245B1/ko active IP Right Grant
- 2013-09-24 NZ NZ706108A patent/NZ706108A/en unknown
- 2013-09-24 BR BR112015006790-5A patent/BR112015006790B1/pt active IP Right Grant
- 2013-09-24 RU RU2015115723A patent/RU2652345C2/ru active IP Right Revival
- 2013-09-24 WO PCT/US2013/061403 patent/WO2014052313A1/en active Application Filing
- 2013-09-24 AU AU2013323766A patent/AU2013323766B2/en not_active Ceased
-
2015
- 2015-03-18 IL IL237810A patent/IL237810B/en active IP Right Grant
-
2016
- 2016-01-27 HK HK16100881.4A patent/HK1212898A1/zh unknown
Also Published As
Publication number | Publication date |
---|---|
AU2013323766B2 (en) | 2017-08-17 |
JP6238991B2 (ja) | 2017-11-29 |
WO2014052313A1 (en) | 2014-04-03 |
EP2900231A1 (en) | 2015-08-05 |
MX2015004006A (es) | 2015-10-29 |
JP2015531374A (ja) | 2015-11-02 |
ES2902850T3 (es) | 2022-03-30 |
BR112015006790A2 (pt) | 2017-07-04 |
KR20150074009A (ko) | 2015-07-01 |
KR102184245B1 (ko) | 2020-11-30 |
US8822537B2 (en) | 2014-09-02 |
CA2885619A1 (en) | 2014-04-03 |
EP2900231B1 (en) | 2021-11-03 |
RU2652345C2 (ru) | 2018-04-25 |
CA2885619C (en) | 2020-09-08 |
EP2900231A4 (en) | 2016-03-02 |
RU2015115723A (ru) | 2016-11-20 |
IL237810B (en) | 2018-06-28 |
NZ706108A (en) | 2018-03-23 |
US20140088195A1 (en) | 2014-03-27 |
AU2013323766A1 (en) | 2015-04-09 |
BR112015006790B1 (pt) | 2022-05-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1212898A1 (zh) | 酮洛芬的局部組合物 | |
IL237035A0 (en) | Antibacterial compound for external use | |
HK1211858A1 (zh) | 雙氯芬酸組合物 | |
GB2506426B (en) | Composition | |
GB201200707D0 (en) | Composition | |
GB201218954D0 (en) | Composition | |
GB2498803B (en) | Composition | |
GB2508825B (en) | Composition | |
EP2878295A4 (en) | COMPOSITION | |
GB201219657D0 (en) | Composition | |
EP2837670A4 (en) | COMPOSITION CONTAINING FLUOROBIPHENYL | |
GB201206035D0 (en) | Composition | |
EP2910538A4 (en) | AGENT COMPOSITION GENERATING GAS | |
EP2910537A4 (en) | AGENT COMPOSITION GENERATING GAS | |
GB201209597D0 (en) | Composition | |
GB201208133D0 (en) | Composition | |
GB201311517D0 (en) | Composition | |
GB201219383D0 (en) | Composition | |
GB201218195D0 (en) | Composition | |
GB201222922D0 (en) | Topical formulation | |
GB201223526D0 (en) | Composition | |
GB201223224D0 (en) | Composition | |
GB201221334D0 (en) | Composition | |
GB201220838D0 (en) | Composition | |
GB201219065D0 (en) | Composition |